LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | TGX221 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4386 | 5013 | 0.8748 | 0.8305 |
MDA-MB-231 | Torin1 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 2243 | 5013 | 0.4475 | 0.2518 |
MDA-MB-231 | Torin2 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 1968 | 5013 | 0.3926 | 0.1774 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 1381 | 5013 | 0.2756 | 0.0189 |
MDA-MB-231 | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 1739 | 5013 | 0.3470 | 0.1156 |
MDA-MB-231 | TWS119 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4878 | 5013 | 0.9730 | 0.9634 |
MDA-MB-231 | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4839 | 5013 | 0.9653 | 0.9529 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4805 | 5013 | 0.9584 | 0.9437 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4866 | 5013 | 0.9707 | 0.9603 |
MDA-MB-231 | WYE-125132 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 2463 | 5013 | 0.4913 | 0.3110 |
MDA-MB-231 | WZ3105 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 831 | 5013 | 0.1658 | -0.1298 |
MDA-MB-231 | XMD11-50 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4526 | 5013 | 0.9028 | 0.8683 |
MDA-MB-231 | Y39983 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4676 | 5013 | 0.9327 | 0.9088 |
MDA-MB-231 | YM 201636 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 5101 | 5013 | 1.0175 | 1.0237 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4180 | 5013 | 0.8337 | 0.7748 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 1311 | 3658 | 5013 | 0.7296 | 0.6338 |
MDA-MB-231 | Sigma A6730 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4755 | 5013 | 0.9484 | 0.9302 |
MDA-MB-231 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 1311 | 761 | 5013 | 0.1518 | -0.1488 |
MDA-MB-231 | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 1311 | 913 | 5013 | 0.1822 | -0.1075 |
MDA-MB-231 | AZD 5438 | 0.37 | uM | LJP6 | 72 | hr | 1311 | 2254 | 5013 | 0.4497 | 0.2547 |
MDA-MB-231 | AZD-6482 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4495 | 5013 | 0.8966 | 0.8599 |
MDA-MB-231 | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 1311 | 2430 | 5013 | 0.4848 | 0.3023 |
MDA-MB-231 | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 1311 | 1981 | 5013 | 0.3953 | 0.1810 |
MDA-MB-231 | AZD8330 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 1522 | 5013 | 0.3037 | 0.0570 |
MDA-MB-231 | Barasertib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 1670 | 5013 | 0.3332 | 0.0970 |